Search results
Showing 451 to 465 of 489 results for %s
Stakeholder registration: guidelines, quality standards and indicators
How to register as a stakeholder to help us develop guidelines, quality standards and indicators.
mini competition can be used to appoint: a supplier for a specific resource(s), or to select a supplier for a resource type for a set...
A guide to the steps to follow when buying sole supplied titles from Lot 1 of our purchasing framework.
Hundreds with rare inherited eye disease to benefit after NICE recommends treatment
NICE recommends idebenone for Leber's hereditary optic neuropathy following clinical evidence of vision improvement.
Learn about NICE's proportionate approach to technology appraisals, which aims to streamline the evaluation process for new health technologies, ensuring timely access to innovative treatments while maintaining rigorous standards.
in an easy to use format, mapped against the Care Quality Commission (CQC)'s 5 key questions. We designed the resource for people...
NICE's equality, diversity, and inclusion roadmap and annual action plan - committed to creating a forward-looking, positive work culture where everyone can thrive.
Read NICE's statement on modern slavery and human trafficking.
The Office for Digital Health strives to accelerate NICE's efforts to deliver innovation to the health and care system.
Ask an expert from NICE International, part of the UK's National Institute for Health and Care Excellence, to speak at a healthcare event in your country
Get expert advice and support from NICE International, part of the UK's National Institute for Health and Care Excellence, for a project in your country
Information about NICE's gender pay gap data for the 12 months leading up to 31 March 2025.
NICE's technology appraisal guidance makes recommendations on the use of new and existing medicines and other treatments within the NHS.
Some people with cystic fibrosis are set to benefit from a new once-daily triple therapy treatment, following NICE's recommendation of Alyftrek in final draft guidance published today.
NICE's partners